Cryptoporus volvatus polysaccharides attenuate LPS-induced expression of pro-inflammatory factors via the TLR2 signaling pathway in human alveolar epithelial cells.
Jian-Ping Zhu,Kai Wu,Jin-You Li,Yan Guan,Yan-Hong Sun,Wen-Jiang Ma,Qiang-Min Xie
DOI: https://doi.org/10.3109/13880209.2015.1042981
2016-01-01
Pharmaceutical Biology
Abstract:Context: Cryptoporus volvatus (Peck) Hubb grows wild in China, and its fruiting bodies have been used traditionally to treat asthma and bronchitis.Objectives: This study evaluates the anti-inflammatory effect of Cryptoporus polysaccharides (CP) extracted from fruiting bodies of C. volvatus on lipopolysaccharide (LPS)-induced pro-inflammatory factors and the signaling pathways involved in human alveolar epithelial cells.Materials and methods: To evaluate the effects of CP on LPS-induced pro-inflammatory factors, A549 cells were pre-incubated with CP 1, 10, and 100g/ml for 1h and then stimulated with LPS 10g/ml for 24h. The expression of pro-inflammatory factors monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor- (TNF-), interleukin-1 (IL-1), Toll-like receptor 2 (TLR2), and phosphorylation of ERK1/2, p38, and NF-B p65 were measured by q-PCR, ELISA, and western blotting.Results: CP decreased LPS-induced mRNA expression of MCP-1, TNF-, and IL-1 (IC50=83.3, 85.2, and 91.6g/ml, respectively) and their correspondent protein expression (IC50=88.6, 76.4, and 81.6g/ml, respectively). Investigation of potential mechanisms indicated that CP 100g/ml reduced LPS-induced expression of TLR2 mRNA (66.9%, p<0.01) and protein (63.2%, p<0.01) that was a result of the decreased pro-inflammatory factors. LPS induction increased the expression of TLR2 and the phosphorylation of p38 and ERK1/2, NF-kB p65 concomitantly. CP 100g/ml inhibited the LPS-induced phosphorylation of the signaling proteins (p<0.05).Conclusions: This suggests that CP pretreatment down-regulates LPS-mediated inflammation in lung epithelial cells. This study further confirmed that CP is a potential anti-inflammatory drug for the treatment of airway inflammatory diseases.